-
Je něco špatně v tomto záznamu ?
Stearate-Induced Apoptosis in Human Pancreatic β-Cells is Associated with Changes in Membrane Protein Expression and These Changes are Inhibited by Oleate
V. Němcová-Fürstová, K. Balušíková, P. Halada, N. Pavlíková, J. Šrámek, J. Kovář,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
30666801
DOI
10.1002/prca.201800104
Knihovny.cz E-zdroje
- MeSH
- apoptóza účinky léků MeSH
- beta-buňky cytologie metabolismus MeSH
- buněčné linie MeSH
- kyselina olejová farmakologie MeSH
- kyseliny stearové farmakologie MeSH
- lidé MeSH
- membránové proteiny biosyntéza MeSH
- regulace genové exprese účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
PURPOSE: Lipotoxicity is implicated in type 2 diabetes pathogenesis. Its molecular mechanisms are not completely understood. The aim of this study is to identify new suspect proteins involved in pancreatic β-cell death induction by saturated fatty acids and its inhibition by unsaturated fatty acids. EXPERIMENTAL DESIGN: Employing 2DE analysis and subsequent western blot confirmation, the differences in membrane/membrane-associated protein expression in human β-cell line NES2Y are assessed during cell death induction by stearate and its inhibition by oleate. RESULTS: Induction of apoptosis by stearate is associated with significantly increased levels of Hsp90β, peroxiredoxin-1, and 14-3-3γ in the membrane fraction of NES2Y cells and significantly decreased levels of annexin A2, annexin A4, and reticulocalbin-2. All these changes are significantly inhibited by oleate co-application. No expression changes are detected after application of stearate together with oleate. Furthermore, the expression of reticulocalbin-2 is significantly decreased after stearate application also in the whole cell lysate. CONCLUSIONS AND CLINICAL RELEVANCE: Several membrane-associated proteins that could be related to pro- and anti-apoptotic signaling initiated by fatty acids in human pancreatic β-cells are identified. As far as we know, annexin A4, reticulocalbin-2, and 14-3-3γ represent novel molecules related to the effect of fatty acids on β-cell viability.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006631
- 003
- CZ-PrNML
- 005
- 20200526135054.0
- 007
- ta
- 008
- 200511s2019 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/prca.201800104 $2 doi
- 035 __
- $a (PubMed)30666801
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Němcová-Fürstová, Vlasta $u Department of Biochemistry, Cell and Molecular Biology & Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- 245 10
- $a Stearate-Induced Apoptosis in Human Pancreatic β-Cells is Associated with Changes in Membrane Protein Expression and These Changes are Inhibited by Oleate / $c V. Němcová-Fürstová, K. Balušíková, P. Halada, N. Pavlíková, J. Šrámek, J. Kovář,
- 520 9_
- $a PURPOSE: Lipotoxicity is implicated in type 2 diabetes pathogenesis. Its molecular mechanisms are not completely understood. The aim of this study is to identify new suspect proteins involved in pancreatic β-cell death induction by saturated fatty acids and its inhibition by unsaturated fatty acids. EXPERIMENTAL DESIGN: Employing 2DE analysis and subsequent western blot confirmation, the differences in membrane/membrane-associated protein expression in human β-cell line NES2Y are assessed during cell death induction by stearate and its inhibition by oleate. RESULTS: Induction of apoptosis by stearate is associated with significantly increased levels of Hsp90β, peroxiredoxin-1, and 14-3-3γ in the membrane fraction of NES2Y cells and significantly decreased levels of annexin A2, annexin A4, and reticulocalbin-2. All these changes are significantly inhibited by oleate co-application. No expression changes are detected after application of stearate together with oleate. Furthermore, the expression of reticulocalbin-2 is significantly decreased after stearate application also in the whole cell lysate. CONCLUSIONS AND CLINICAL RELEVANCE: Several membrane-associated proteins that could be related to pro- and anti-apoptotic signaling initiated by fatty acids in human pancreatic β-cells are identified. As far as we know, annexin A4, reticulocalbin-2, and 14-3-3γ represent novel molecules related to the effect of fatty acids on β-cell viability.
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a regulace genové exprese $x účinky léků $7 D005786
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a beta-buňky $x cytologie $x metabolismus $7 D050417
- 650 _2
- $a membránové proteiny $x biosyntéza $7 D008565
- 650 _2
- $a kyselina olejová $x farmakologie $7 D019301
- 650 _2
- $a kyseliny stearové $x farmakologie $7 D013229
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Balušíková, Kamila $u Department of Biochemistry, Cell and Molecular Biology & Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Halada, Petr $u Laboratory of Molecular Structure Characterization, Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Pavlíková, Nela $u Department of Biochemistry, Cell and Molecular Biology & Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Šrámek, Jan $u Department of Biochemistry, Cell and Molecular Biology & Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Kovář, Jan $u Department of Biochemistry, Cell and Molecular Biology & Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- 773 0_
- $w MED00157628 $t Proteomics. Clinical applications $x 1862-8354 $g Roč. 13, č. 4 (2019), s. e1800104
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30666801 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200526135050 $b ABA008
- 999 __
- $a ok $b bmc $g 1525489 $s 1096687
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 13 $c 4 $d e1800104 $e 20190131 $i 1862-8354 $m Proteomics. Clinical applications $n Proteomics Clin Appl $x MED00157628
- LZP __
- $a Pubmed-20200511